Last reviewed · How we verify
YAZ (SH T00186, BAY86-5300) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
YAZ (SH T00186, BAY86-5300) (YAZ (SH T00186, BAY86-5300)) — Bayer. YAZ is a combination oral contraceptive that contains drospirenone and ethinyl estradiol, which work to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| YAZ (SH T00186, BAY86-5300) TARGET | YAZ (SH T00186, BAY86-5300) | Bayer | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- YAZ (SH T00186, BAY86-5300) CI watch — RSS
- YAZ (SH T00186, BAY86-5300) CI watch — Atom
- YAZ (SH T00186, BAY86-5300) CI watch — JSON
- YAZ (SH T00186, BAY86-5300) alone — RSS
Cite this brief
Drug Landscape (2026). YAZ (SH T00186, BAY86-5300) — Competitive Intelligence Brief. https://druglandscape.com/ci/yaz-sh-t00186-bay86-5300. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab